Matrix Metalloproteinases in Brain Injury
The DOI matches its Crossref record.
Abstract
Proteolytic remodeling of the extracellular matrix occurs normally during development and pathologically in arthritis, tumor metastasis, wound healing, and angiogenesis. The major extracellular matrix-degrading proteinases belong to the matrix metalloproteinase (MMP) and plasminogen activator gene families. Intracerebral injection of 72-kDa type IV collagenase (gelatinase A) opens the blood-brain barrier. During hemorrhagic brain injury or intracerebral injection of proinflammatory cytokines, endogenous production of 92-kDa type IV collagenase (gelatinase B) occurs. The gelatinase B gene contains a phorbol ester responsive region (TRE) that binds AP-1 proteins, including c-Fos/c-Jun dimer, the early immediate response gene products. Maximum production of gelatinase B in injury occurs between 16 and 24 h, making this a late effector gene. The serine proteinase, urokinase-type plasminogen activator (uPA), is also produced at that time. Gelatinases and plasminogen activators work in concert to disrupt basement membranes proteolytically. A similar process opens the blood-brain barrier after ischemic and hemorrhagic brain injury, leading to secondary vasogenic brain edema. Delayed damage by proteolytic cascade enzymes provides opportunities for treatment much later than had been thought possible. Potential treatments possible in this second therapeutic window include interfering with the genes that produce the MMPs or inhibiting the action of the gene products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Matrix metalloproteinases in neuroinflammation
Rosenberg, G. A. (2002) · Glia · doi:10.1002/glia.10108 · Cited by 868
Self-citationRomanic, A. M., White, R. F., Arleth, A. J., Ohlstein, E. H., & Barone, F. C. (1998) · Stroke · doi:10.1161/01.str.29.5.1020 · Cited by 739
The optic nerve head in glaucoma: role of astrocytes in tissue remodeling
Hernandez, M. R. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00017-8 · Cited by 570
Multiple roles for MMPs and TIMPs in cerebral ischemia
Cunningham, L. A., Wetzel, M., & Rosenberg, G. A. (2005) · Glia · doi:10.1002/glia.20169 · Cited by 411
Self-citationVascular Events After Spinal Cord Injury: Contribution to Secondary Pathogenesis
Mautes, A. E., Weinzierl, M. R., Donovan, F., & Noble, L. J. (2000) · Physical Therapy · doi:10.1093/ptj/80.7.673 · Cited by 405
BETHEA, J. R., NAGASHIMA, H., ACOSTA, M. C., BRICENO, C., GOMEZ, F., MARCILLO, A. E., LOOR, K., GREEN, J., & DIETRICH, W. D. (1999) · Journal of Neurotrauma · doi:10.1089/neu.1999.16.851 · Cited by 401
Traumatic Spinal Cord Injury Induces Nuclear Factor-κB Activation
Bethea, J. R., Castro, M., Keane, R. W., Lee, T. T., Dietrich, W. D., & Yezierski, R. P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03251.1998 · Cited by 394
Matrix Metalloproteinases in Cerebrovascular Disease
Mun-Bryce, S., & Rosenberg, G. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00001 · Cited by 348
Self-citationLapchak, P. A., Chapman, D. F., & Zivin, J. A. (2000) · Stroke · doi:10.1161/01.str.31.12.3034 · Cited by 339
Clark, A. W., Krekoski, C. A., Bou, S.-S., Chapman, K. R., & Edwards, D. R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00859-8 · Cited by 328
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
Anthony, D. C., Ferguson, B., Matyzak, M. K., Miller, K. M., Esiri, M. M., & Perry, V. H. (1997) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1997.00066.x · Cited by 268
Lee, S.-R., Tsuji, K., Lee, S.-R., & Lo, E. H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4243-03.2004 · Cited by 241
“The pathologic role for MMPs in focal brain injury has been attributed primarily to neurovascular matrix degradation , blood – brain barrier disruption , and ultimately hemorrhage , edema , and increased inflammatory influx ( Rosenberg , 1995 ; Mun - Bryce and Rosenberg , 1998 ; Romanic et al .”
InfluentialExtracellular matrix degradation by metalloproteinases and central nervous system diseases
Lukes, A., Mun-Bryce, S., Lukes, M., & Rosenberg, G. A. (1999) · Molecular Neurobiology · doi:10.1007/bf02821717 · Cited by 230
Self-citationMechanisms of acute brain injury after subarachnoid hemorrhage
Sehba, F. A., & Bederson, J. B. (2006) · Neurological Research · doi:10.1179/016164106x114991 · Cited by 210
Muir, E. M., Adcock, K. H., Morgenstern, D. A., Clayton, R., von Stillfried, N., Rhodes, K., Ellis, C., Fawcett, J. W., & Rogers, J. H. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00132-8 · Cited by 206
Groblewska, M., Siewko, M., Mroczko, B., & Szmitkowski, M. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0002 · Cited by 180
Verma, S., Kumar, M., Gurjav, U., Lum, S., & Nerurkar, V. R. (2010) · Virology · doi:10.1016/j.virol.2009.10.036 · Cited by 151
“Excess MMP production and activation is the key pathophysiological hallmark of several neurodegenerative diseases (Cunningham, Wetzel, and Rosenberg, 2005; Hu et al., 2007; Rosenberg, 1995; Rosenberg, 2002).”
BackgroundRivera, S., Tremblay, E., Timsit, S., Canals, O., Ben-Ari, Y., & Khrestchatisky, M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04223.1997 · Cited by 135
Metadata
- Authors
- ROSENBERG, G. A.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 1995-10
- Volume
- 12
- Issue
- 5
- Pages
- 833-842
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W1997681415
- Cited by
- 218
- References
- 0
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.